首页> 美国卫生研究院文献>Case Reports in Oncology >Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

【2h】

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

机译：mFOLFOX6 / XELOX +贝伐单抗治疗晚期肺癌并发肺转移的长期生存2例

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundColorectal cancer (CRC) with lung metastases has an unfavorable prognosis. However, nowadays, even advanced CRC can have a favorable outcome in certain cases. A complete response (CR) is a rare event in advanced CRC with lung metastases. Herein, we report 2 rare cases of advanced CRC attaining a CR.

机译：背景患有肺转移的结直肠癌（CRC）的预后不良。但是，如今，即使在某些情况下，即使晚期CRC也可以取得良好的疗效。在具有肺转移的晚期CRC中，完全缓解（CR）是罕见的事件。在此，我们报告了2例罕见的晚期CRC达到CR的情况。

著录项

期刊名称 Case Reports in Oncology
作者
Yuta Ushida; Eiji Shinozaki; Keisho Chin; Mitsukuni Suenaga; Daisuke Takahari; Masato Ozaka; Mariko Ogura; Takashi Ichimura; Takeru Wakatsuki; Kensei Yamaguchi;
展开▼
作者单位

展开▼
年(卷),期 2018(11),2
年度 2018
页码 601–608
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Colorectal cancer Complete response Long-term survival Bevacizumab Lung metastasis;

机译：大肠癌;完全缓解;长期生存;贝伐单抗;肺转移;

相似文献

外文文献
中文文献
专利

1. Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab [J] . Ushida Y., Shinozaki E., Chin K., Case Reports in Oncology . 2018,第2期

机译：mFOLFOX6 / XELOX +贝伐单抗治疗晚期肺癌并发肺转移的长期生存2例
2. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival [J] . Yasuno Masamichi, Uetake Hiroyuki, Ishiguro Megumi, International journal of clinical oncology . 2019,第5期

机译：Mfolfox6加上贝伐单抗治疗肝脏癌的肝脏转移，这些癌症不适合前期切除（TRICC0808）：包括最终存活的最终分析的多中心期II试验
3. A Multicenter Phase II Trial of mFOLFOX6 Plus Bevacizumab to Treat Liver-Only Metastases of Colorectal Cancer that are Unsuitable for Upfront Resection (TRICC0808) [J] . Uetake Hiroyuki, Yasuno Masamichi, Ishiguro Megumi, Annals of surgical oncology . 2015,第3期

机译：mFOLFOX6加贝伐单抗的多中心II期临床试验，用于治疗不适合前期切除的仅结直肠癌的肝脏转移灶（TRICC0808）
4. Survival Benefit of Pelvic Exenteration for Locally Advanced Colorectal Cancer with Lymph Node Metastases [C] . J. Hida, T. Yoshifuji, F. Sugiura, International Society of University Colon and Rectal Surgeons . 2008

机译：淋巴结转移盆腔盆腔盆腔盆腔出生的生存效益
5. Alpha-methylacyl-CoA racemase: A candidate gene for prostate cancer and advanced distal colorectal adenomas in the prostate, lung, colorectal, and ovarian cancer screening trial. [D] . Daugherty, Sarah. 2007

机译：α-甲基酰基辅酶A消旋酶：在前列腺癌，肺癌，结肠直肠癌和卵巢癌筛查试验中，前列腺癌和晚期远端结肠直肠腺瘤的候选基因。
6. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival [O] . Masamichi Yasuno, Hiroyuki Uetake, Megumi Ishiguro, -1

机译：mFOLFOX6加上贝伐单抗用于治疗不适合前期切除的仅结直肠癌的仅肝转移灶（TRICC0808）：一项多中心II期临床试验包括最终生存期分析
7. Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab [O] . Yuta Ushida, Eiji Shinozaki, Keisho Chin, 2018

机译：用MfolfoX6 / Xelox + Bevacizumab处理同步肺转移的高级结直肠癌长期存活的两种情况

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

摘要

著录项

相似文献

相关主题

期刊订阅